1. Tysabri (Natalizumab) Natalizumab (manufactured by Biogen Idec as Tysabri; previously named Antegren) is a humanized monoclonal [...]
Opinions voiced by multiple sclerosis (MS) patients as to what they most want from, and like in, an MS treatment differ widely, although [...]
An extension of the phase II BOLD study found sustained reductions in gadolinium-enhancing T1 and new or enlarging T2 lesions over 2 years [...]
The collective microenvironment of gut bacteria, called the gut microbiome, has come to receive attention in many research labs for its [...]
High blood pressure may be linked to greater overall disability in people with multiple sclerosis (MS), although the rate at which [...]
Individuals with genetically increased body mass indexes were at a greater risk for developing multiple sclerosis (MS), according to [...]
A team of scientists has created a new form of a vaccine used for the treatment of multiple sclerosis, one of the most severe [...]
Patients with multiple sclerosis (MS) have higher levels of a micro-RNA called miR-150 in their cerebrospinal fluid, a liquid surrounding [...]
Multiple sclerosis-related optic neuropathy can be reversed with allergy drug (antihistamine): study
Multiple sclerosis-related optic neuropathy can be reversed with allergy drugs (antihistamines), according to research. The preliminary [...]
